Resources

Access expert content and insights, including whitepapers, case studies, presentations, and other valuable resources here.

Trends in the Virotherapy Market Driving Accelerated IND …

Virotherapy platforms are increasingly being used in the development of novel and transformative therapeutics, offering the potential to drast…

Bringing Virotherapies to Clinic: Understanding the IND A…

The use of viruses as therapies have come a long way since the early virotherapy research of Virchow, Lister, Koch, Pasteur in the late 19th c…

Suspension vs. Adherent: Cell Culture Platforms for Oncol…

Selecting the right producer cell line for the development and manufacturing of oncolytic virus (OV) therapeutics can be challenging. The inhe…

Realizing the Potential of Oncolytic Viruses

The oncology treatment space is advancing rapidly, with the number of clinical trials studying therapies targeting cancer indications up 56% f…

Key Challenges in Scaling Oncolytic Virus Manufacturing

The oncolytic virus market is expected to reach $609 million by 2028, growing at a compound annual growth rate of 26.2%.[1] This will be drive…

Cell and Virus Banking: 5 Considerations for Planning You…

Rapidly emerging as an important therapeutic tool for the treatment of cancer, oncolytic viruses (OVs) can be specifically engineered for tumo…